We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

7 hedge funds and large institutions have $377K invested in Genetic Technologies Ltd. in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

99% more capital invested

Capital invested by funds: $189K → $377K (+$188K)

17% more funds holding

Funds holding: 6 → 7 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$315K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$96.1K
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$7.87K
4
Morgan Stanley
Morgan Stanley
New York
+$1.13K
5
Simplex Trading
Simplex Trading
Illinois
+$574

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$633

GENE Hedge Fund Activity: Q2 2024 in Review

7 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2024, worth a combined $377K — up 99% from $189K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new GENE positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $315K. The largest seller was UBS Group, exiting entirely with an estimated $633 sold.

  • 7 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2024, up from 6 in Q1 2024.
  • Funds reported $377K of Genetic Technologies Ltd. stock for Q2 2024, up 99% quarter-over-quarter.
  • 2 funds opened new Genetic Technologies Ltd. positions in Q2 2024 and 1 closed out, a net change of +1 holder.
  • The largest Genetic Technologies Ltd. buyer in Q2 2024 was Armistice Capital, an estimated $315K added.
  • The largest Genetic Technologies Ltd. seller in Q2 2024 was UBS Group, an estimated $633 sold.

Based on aggregated 13F filings for Q2 2024.